Literature DB >> 24484457

Virulence factors and infection ability of Pseudomonas aeruginosa isolates from a hydropathic facility and respiratory infections.

S G Pereira1, A C Rosa, A S Ferreira, L M Moreira, D N Proença, P V Morais, O Cardoso.   

Abstract

AIMS: To compare the virulence pool and acute infection ability of Pseudomonas aeruginosa isolates from a hydropathic facility, used to treat respiratory conditions by inhalation of untreated natural mineral water, with clinical isolates from respiratory infections. METHODS AND
RESULTS: Pseudomonas aeruginosa isolates from a hydropathic facility and from respiratory infections were typed by pulsed-field gel electrophoresis. Nonclonal representatives of each population were selected. 18 virulence-encoding genes were screened by polymerase chain reaction and statistically compared by multiple correspondence analysis. Homogeneous distribution of genes between populations but higher genetic association in aquatic isolates was observed, as well as distinct virulence pool according to location in the water system. Acute infection ability of selected isolates from each population, in Galleria mellonella model, showed lower LD50 of the majority of the hydropathic isolates and significant variations in LD50 of biofilm isolates from different equipments.
CONCLUSIONS: Hydrotherapy Ps. aeruginosa isolates present similar virulence to isolates from respiratory infections. Hydrotherapy users may be exposed to different microbiological risks when using different treatment equipments. SIGNIFICANCE AND IMPACT OF THE STUDY: Twenty-one million people use hydropathic facilities in Europe, and the majority present risk factors to pneumonia. This study demonstrates the health risk associated with this practice. Revision of European regulations should be considered.
© 2014 The Society for Applied Microbiology.

Entities:  

Keywords:  Pseudomonas aeruginosa; infection control; pneumonia; respiratory infections; surveillance; waterborne infections

Mesh:

Substances:

Year:  2014        PMID: 24484457     DOI: 10.1111/jam.12463

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  8 in total

1.  Virulence factors as predictive tools for drug resistance in Pseudomonas aeruginosa.

Authors:  Sónia Gonçalves Pereira; Ana Cristina Rosa; Olga Cardoso
Journal:  Virulence       Date:  2015-05-07       Impact factor: 5.882

Review 2.  Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections.

Authors:  Diana P Pires; Diana Vilas Boas; Sanna Sillankorva; Joana Azeredo
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

3.  Global reprogramming of virulence and antibiotic resistance in Pseudomonas aeruginosa by a single nucleotide polymorphism in elongation factor, fusA1.

Authors:  Eve A Maunders; Rory C Triniman; Joshua Western; Taufiq Rahman; Martin Welch
Journal:  J Biol Chem       Date:  2020-09-17       Impact factor: 5.157

4.  The Alteration of Nasopharyngeal and Oropharyngeal Microbiota in Children with MPP and Non-MPP.

Authors:  Zhiwei Lu; Wenkui Dai; Yanhong Liu; Qian Zhou; Heping Wang; Dongfang Li; Zhenyu Yang; Yinhu Li; Gan Xie; Shuaicheng Li; Yuejie Zheng
Journal:  Genes (Basel)       Date:  2017-12-11       Impact factor: 4.096

Review 5.  Matrix exopolysaccharides; the sticky side of biofilm formation.

Authors:  Eve Maunders; Martin Welch
Journal:  FEMS Microbiol Lett       Date:  2017-07-06       Impact factor: 2.742

6.  Association between Beta-lactam Antibiotic Resistance and Virulence Factors in AmpC Producing Clinical Strains of P. aeruginosa.

Authors:  Sanaz Dehbashi; Hamed Tahmasebi; Mohammad Reza Arabestani
Journal:  Osong Public Health Res Perspect       Date:  2018-12

7.  The involvement of McpB chemoreceptor from Pseudomonas aeruginosa PAO1 in virulence.

Authors:  Cristina García-Fontana; Juan I Vílchez; Marta González-Requena; Jesús González-López; Tino Krell; Miguel A Matilla; Maximino Manzanera
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

8.  Non-Antimicrobial Drugs: Etodolac as a Possible Antimicrobial or Adjuvant Agent Against ESKAPE Pathogens.

Authors:  Sónia G Pereira; Vanessa S Domingues; João Theriága; Maria de Jesus Chasqueira; Paulo Paixão
Journal:  Open Microbiol J       Date:  2018-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.